Moderna’s vax approved for younger children

A second COVID-19 vaccine for ages 6-11 'welcomed' as a way to boost uptake
Associate Professor Paul Griffin.

Another COVID-19 vaccine will soon be available for younger children with the TGA’s provisional approval of Moderna’s Spikevax for those aged six and over. 

The provisional approval follows “careful consideration” of US and Canadian vaccine trials, the watchdog said in a statement.